世界の女性用性的欲求低下障害治療市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Female Hypoactive Sexual Desire Disorder Therapeutics Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-107A12275 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、84ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、女性用性的欲求低下障害治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。女性用性的欲求低下障害治療の種類別市場規模（BP-101、ブレメラノチド、ゲピロン塩酸塩ER、PVT-011、その他）、用途別市場規模（外来患者、入院患者）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・女性用性的欲求低下障害治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Emotional Brain BV、GlaxoSmithKline Plc、Palatin Technologies Inc、Pivot Pharmaceuticals Inc、Strategic Science & Technologies LLC ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：BP-101、ブレメラノチド、ゲピロン塩酸塩ER、PVT-011、その他 ・用途別分析2016年-2026年：外来患者、入院患者 ・女性用性的欲求低下障害治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・女性用性的欲求低下障害治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・女性用性的欲求低下障害治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・女性用性的欲求低下障害治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・女性用性的欲求低下障害治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Female Hypoactive Sexual Desire Disorder Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Female Hypoactive Sexual Desire Disorder Therapeutics size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Female Hypoactive Sexual Desire Disorder Therapeutics market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Female Hypoactive Sexual Desire Disorder Therapeutics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
BP-101
Bremelanotide
Gepirone Hydrochloride ER
PVT-011
Others

Market segment by Application, can be divided into
Out-Patient
In-Patient

Market segment by players, this report covers
Emotional Brain BV
GlaxoSmithKline Plc
Palatin Technologies Inc
Pivot Pharmaceuticals Inc
Strategic Science & Technologies LLC

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Female Hypoactive Sexual Desire Disorder Therapeutics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Female Hypoactive Sexual Desire Disorder Therapeutics, with revenue, gross margin and global market share of Female Hypoactive Sexual Desire Disorder Therapeutics from 2019 to 2021.
Chapter 3, the Female Hypoactive Sexual Desire Disorder Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Female Hypoactive Sexual Desire Disorder Therapeutics market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Female Hypoactive Sexual Desire Disorder Therapeutics research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of Female Hypoactive Sexual Desire Disorder Therapeutics
1.2 Classification of Female Hypoactive Sexual Desire Disorder Therapeutics by Type
1.2.1 Overview: Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share by Type in 2020
1.2.3 BP-101
1.2.4 Bremelanotide
1.2.5 Gepirone Hydrochloride ER
1.2.6 PVT-011
1.2.7 Others
1.3 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market by Application
1.3.1 Overview: Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Out-Patient
1.3.3 In-Patient
1.4 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size & Forecast
1.5 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size and Forecast by Region
1.5.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Region, (2016-2021)
1.5.3 North America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size and Prospect (2016-2026)
1.5.4 Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Market Size and Prospect (2016-2026)
1.5.6 South America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Female Hypoactive Sexual Desire Disorder Therapeutics Market Drivers
1.6.2 Female Hypoactive Sexual Desire Disorder Therapeutics Market Restraints
1.6.3 Female Hypoactive Sexual Desire Disorder Therapeutics Trends Analysis
2 Company Profiles
2.1 Emotional Brain BV
2.1.1 Emotional Brain BV Details
2.1.2 Emotional Brain BV Major Business
2.1.3 Emotional Brain BV Female Hypoactive Sexual Desire Disorder Therapeutics Product and Solutions
2.1.4 Emotional Brain BV Female Hypoactive Sexual Desire Disorder Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Emotional Brain BV Recent Developments and Future Plans
2.2 GlaxoSmithKline Plc
2.2.1 GlaxoSmithKline Plc Details
2.2.2 GlaxoSmithKline Plc Major Business
2.2.3 GlaxoSmithKline Plc Female Hypoactive Sexual Desire Disorder Therapeutics Product and Solutions
2.2.4 GlaxoSmithKline Plc Female Hypoactive Sexual Desire Disorder Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 GlaxoSmithKline Plc Recent Developments and Future Plans
2.3 Palatin Technologies Inc
2.3.1 Palatin Technologies Inc Details
2.3.2 Palatin Technologies Inc Major Business
2.3.3 Palatin Technologies Inc Female Hypoactive Sexual Desire Disorder Therapeutics Product and Solutions
2.3.4 Palatin Technologies Inc Female Hypoactive Sexual Desire Disorder Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Palatin Technologies Inc Recent Developments and Future Plans
2.4 Pivot Pharmaceuticals Inc
2.4.1 Pivot Pharmaceuticals Inc Details
2.4.2 Pivot Pharmaceuticals Inc Major Business
2.4.3 Pivot Pharmaceuticals Inc Female Hypoactive Sexual Desire Disorder Therapeutics Product and Solutions
2.4.4 Pivot Pharmaceuticals Inc Female Hypoactive Sexual Desire Disorder Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Pivot Pharmaceuticals Inc Recent Developments and Future Plans
2.5 Strategic Science & Technologies LLC
2.5.1 Strategic Science & Technologies LLC Details
2.5.2 Strategic Science & Technologies LLC Major Business
2.5.3 Strategic Science & Technologies LLC Female Hypoactive Sexual Desire Disorder Therapeutics Product and Solutions
2.5.4 Strategic Science & Technologies LLC Female Hypoactive Sexual Desire Disorder Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Strategic Science & Technologies LLC Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Female Hypoactive Sexual Desire Disorder Therapeutics Players Market Share
3.2.2 Top 10 Female Hypoactive Sexual Desire Disorder Therapeutics Players Market Share
3.2.3 Market Competition Trend
3.3 Female Hypoactive Sexual Desire Disorder Therapeutics Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Market Share by Type (2016-2021)
4.2 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share by Application (2016-2021)
5.2 Female Hypoactive Sexual Desire Disorder Therapeutics Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Type (2016-2026)
6.2 North America Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Application (2016-2026)
6.3 North America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Country
6.3.1 North America Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Country (2016-2026)
6.3.2 United States Female Hypoactive Sexual Desire Disorder Therapeutics Market Size and Forecast (2016-2026)
6.3.3 Canada Female Hypoactive Sexual Desire Disorder Therapeutics Market Size and Forecast (2016-2026)
6.3.4 Mexico Female Hypoactive Sexual Desire Disorder Therapeutics Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Type (2016-2026)
7.2 Europe Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Application (2016-2026)
7.3 Europe Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Country
7.3.1 Europe Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Country (2016-2026)
7.3.2 Germany Female Hypoactive Sexual Desire Disorder Therapeutics Market Size and Forecast (2016-2026)
7.3.3 France Female Hypoactive Sexual Desire Disorder Therapeutics Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Female Hypoactive Sexual Desire Disorder Therapeutics Market Size and Forecast (2016-2026)
7.3.5 Russia Female Hypoactive Sexual Desire Disorder Therapeutics Market Size and Forecast (2016-2026)
7.3.6 Italy Female Hypoactive Sexual Desire Disorder Therapeutics Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Type (2016-2026)
8.2 Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Application (2016-2026)
8.3 Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Region
8.3.1 Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Region (2016-2026)
8.3.2 China Female Hypoactive Sexual Desire Disorder Therapeutics Market Size and Forecast (2016-2026)
8.3.3 Japan Female Hypoactive Sexual Desire Disorder Therapeutics Market Size and Forecast (2016-2026)
8.3.4 South Korea Female Hypoactive Sexual Desire Disorder Therapeutics Market Size and Forecast (2016-2026)
8.3.5 India Female Hypoactive Sexual Desire Disorder Therapeutics Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Female Hypoactive Sexual Desire Disorder Therapeutics Market Size and Forecast (2016-2026)
8.3.7 Australia Female Hypoactive Sexual Desire Disorder Therapeutics Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Type (2016-2026)
9.2 South America Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Application (2016-2026)
9.3 South America Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Country
9.3.1 South America Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Country (2016-2026)
9.3.2 Brazil Female Hypoactive Sexual Desire Disorder Therapeutics Market Size and Forecast (2016-2026)
9.3.3 Argentina Female Hypoactive Sexual Desire Disorder Therapeutics Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Type (2016-2026)
10.2 Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Application (2016-2026)
10.3 Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Country
10.3.1 Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Country (2016-2026)
10.3.2 Turkey Female Hypoactive Sexual Desire Disorder Therapeutics Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Female Hypoactive Sexual Desire Disorder Therapeutics Market Size and Forecast (2016-2026)
10.3.4 UAE Female Hypoactive Sexual Desire Disorder Therapeutics Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Female Hypoactive Sexual Desire Disorder Therapeutics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue (USD Million) by Region (2016-2021)
Table 5. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share by Region (2021-2026)
Table 6. Emotional Brain BV Corporate Information, Head Office, and Major Competitors
Table 7. Emotional Brain BV Major Business
Table 8. Emotional Brain BV Female Hypoactive Sexual Desire Disorder Therapeutics Product and Solutions
Table 9. Emotional Brain BV Female Hypoactive Sexual Desire Disorder Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. GlaxoSmithKline Plc Corporate Information, Head Office, and Major Competitors
Table 11. GlaxoSmithKline Plc Major Business
Table 12. GlaxoSmithKline Plc Female Hypoactive Sexual Desire Disorder Therapeutics Product and Solutions
Table 13. GlaxoSmithKline Plc Female Hypoactive Sexual Desire Disorder Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Palatin Technologies Inc Corporate Information, Head Office, and Major Competitors
Table 15. Palatin Technologies Inc Major Business
Table 16. Palatin Technologies Inc Female Hypoactive Sexual Desire Disorder Therapeutics Product and Solutions
Table 17. Palatin Technologies Inc Female Hypoactive Sexual Desire Disorder Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Pivot Pharmaceuticals Inc Corporate Information, Head Office, and Major Competitors
Table 19. Pivot Pharmaceuticals Inc Major Business
Table 20. Pivot Pharmaceuticals Inc Female Hypoactive Sexual Desire Disorder Therapeutics Product and Solutions
Table 21. Pivot Pharmaceuticals Inc Female Hypoactive Sexual Desire Disorder Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Strategic Science & Technologies LLC Corporate Information, Head Office, and Major Competitors
Table 23. Strategic Science & Technologies LLC Major Business
Table 24. Strategic Science & Technologies LLC Female Hypoactive Sexual Desire Disorder Therapeutics Product and Solutions
Table 25. Strategic Science & Technologies LLC Female Hypoactive Sexual Desire Disorder Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue (USD Million) by Players (2019-2021)
Table 27. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Share by Players (2019-2021)
Table 28. Breakdown of Female Hypoactive Sexual Desire Disorder Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 29. Female Hypoactive Sexual Desire Disorder Therapeutics Players Head Office, Products and Services Provided
Table 30. Female Hypoactive Sexual Desire Disorder Therapeutics Mergers & Acquisitions in the Past Five Years
Table 31. Female Hypoactive Sexual Desire Disorder Therapeutics New Entrants and Expansion Plans
Table 32. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue (USD Million) by Type (2016-2021)
Table 33. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Share by Type (2016-2021)
Table 34. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Forecast by Type (2021-2026)
Table 35. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Application (2016-2021)
Table 36. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Forecast by Application (2021-2026)
Table 37. North America Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 38. North America Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 39. North America Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 40. North America Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 41. North America Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 42. North America Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 43. Europe Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 44. Europe Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 45. Europe Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 46. Europe Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 47. Europe Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 48. Europe Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 49. Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 50. Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 51. Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 52. Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 53. Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Region (2016-2021) & (USD Million)
Table 54. Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Region (2021-2026) & (USD Million)
Table 55. South America Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 56. South America Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 57. South America Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 58. South America Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 59. South America Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 60. South America Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 61. Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 62. Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 63. Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 64. Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 65. Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 66. Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Female Hypoactive Sexual Desire Disorder Therapeutics Picture
Figure 2. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share by Type in 2020
Figure 3. BP-101
Figure 4. Bremelanotide
Figure 5. Gepirone Hydrochloride ER
Figure 6. PVT-011
Figure 7. Others
Figure 8. Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share by Application in 2020
Figure 9. Out-Patient Picture
Figure 10. In-Patient Picture
Figure 11. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share by Region (2016-2026)
Figure 14. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share by Region in 2020
Figure 15. North America Female Hypoactive Sexual Desire Disorder Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Female Hypoactive Sexual Desire Disorder Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Female Hypoactive Sexual Desire Disorder Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa Female Hypoactive Sexual Desire Disorder Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Female Hypoactive Sexual Desire Disorder Therapeutics Market Drivers
Figure 21. Female Hypoactive Sexual Desire Disorder Therapeutics Market Restraints
Figure 22. Female Hypoactive Sexual Desire Disorder Therapeutics Market Trends
Figure 23. Emotional Brain BV Recent Developments and Future Plans
Figure 24. GlaxoSmithKline Plc Recent Developments and Future Plans
Figure 25. Palatin Technologies Inc Recent Developments and Future Plans
Figure 26. Pivot Pharmaceuticals Inc Recent Developments and Future Plans
Figure 27. Strategic Science & Technologies LLC Recent Developments and Future Plans
Figure 28. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Share by Players in 2020
Figure 29. Female Hypoactive Sexual Desire Disorder Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 30. Global Top 3 Players Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share in 2020
Figure 31. Global Top 10 Players Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share in 2020
Figure 32. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 33. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Share by Type in 2020
Figure 34. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Share Forecast by Type (2021-2026)
Figure 35. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Share by Application in 2020
Figure 36. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Share Forecast by Application (2021-2026)
Figure 37. North America Female Hypoactive Sexual Desire Disorder Therapeutics Sales Market Share by Type (2016-2026)
Figure 38. North America Female Hypoactive Sexual Desire Disorder Therapeutics Sales Market Share by Application (2016-2026)
Figure 39. North America Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share by Country (2016-2026)
Figure 40. United States Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Canada Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Mexico Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Europe Female Hypoactive Sexual Desire Disorder Therapeutics Sales Market Share by Type (2016-2026)
Figure 44. Europe Female Hypoactive Sexual Desire Disorder Therapeutics Sales Market Share by Application (2016-2026)
Figure 45. Europe Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share by Country (2016-2026)
Figure 46. Germany Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. France Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. United Kingdom Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Russia Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Italy Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Sales Market Share by Type (2016-2026)
Figure 52. Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Sales Market Share by Application (2016-2026)
Figure 53. Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share by Region (2016-2026)
Figure 54. China Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Japan Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. South Korea Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. India Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Southeast Asia Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Australia Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. South America Female Hypoactive Sexual Desire Disorder Therapeutics Sales Market Share by Type (2016-2026)
Figure 61. South America Female Hypoactive Sexual Desire Disorder Therapeutics Sales Market Share by Application (2016-2026)
Figure 62. South America Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share by Country (2016-2026)
Figure 63. Brazil Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Argentina Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Middle East and Africa Female Hypoactive Sexual Desire Disorder Therapeutics Sales Market Share by Type (2016-2026)
Figure 66. Middle East and Africa Female Hypoactive Sexual Desire Disorder Therapeutics Sales Market Share by Application (2016-2026)
Figure 67. Middle East and Africa Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share by Country (2016-2026)
Figure 68. Turkey Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Saudi Arabia Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. UAE Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Methodology
Figure 72. Research Process and Data Source

---